Xi An Zhi Xiang Chemistry Technology Co., Ltd

Country/Region: China     State/Province: Beijing

Main Products: Axitinib(CAS ***-85-0), Masitinib(CAS ***-79-5), Tandutinib(***-13-2), Nilotinib(CAS ***-10-0), Caertinib(CAS ***-28-7), Lapatinib, Vandetanib( CAS ***-73-3), Raltegravir(CAS ***-72-1), Moxifloxacin(CAS ***-09-2), Ezetimibe, Axitinib(CAS 319460-85-0)

Company Introduction
Xi an Zhi Xiang Chemistry Technology Co., Ltd is setting a benchmark in apparel and garments industry with trendy and quality Ezetimibe. Xi An Zhi Xiang Chemistry Technology Co., Ltd is a headquartered in Beijing, Beijing, China, with a technology advanced facility boasting yearly profit estimating around Approx 0.5 Billion US Dollar. We understand that aesthetic appeal is the foremost requirement when it comes to axitinib(CAS 319460-85-0),masitinib(CAS 790299-79-5),tandutinib(387867-13-2),nilotinib(CAS 641571-10-0),caertinib(CAS 267543-28-7),lapatinib,vandetanib( CAS 443913-73-3),Raltegravir(CAS 871038-72-1),moxifloxacin(CAS 151096-09-2),Ezetimibe and to make that last long we ensure that raw material are sourced only form the best. Constant strive to speedy shipment and quality consistency helped us capture over Canada,Chile,Ecuador,Thailand,United Kingdom export market share and export ratio value raging around Below US$1 Million with 20 Years of export history. Established back in 2000, as Ezetimibe Manufacturer and Retailer with Initial business capital of US$5 Million - US$10 Million we started off as LLC (Limited Liability Corp) entity under Third Party.
Company Overview

Business Type: Manufacturer

Business Nature: Manufacturer

Year Established: 2000, 2000

Legal Status: Third Party

Ownership: LLC (Limited Liability Corp)

Employees: 101 - 200 People

Factory Size: Below 1, 000 square meters

R&D Team Size: 5 - 10 People

Certifications: GMP

Contact Information

Contact Person: xiguo sui

Designation: MD

Department: Manager

Telephone: 86-13488262026

Business Information

Main Markets: Canada (27%) Chile (21%) Thailand (18%) United Kingdom (15%) Ecuador (11%)

Export Focus: Canada, Chile, Ecuador, Thailand, United Kingdom

Contract Services: Design Service Offered

Trade & Financial Information

Annual Revenue: Approx 0.5 Billion US Dollar

Registered Capital: US$5 Million - US$10 Million

Export Percentage: 1% - 10%

Payment Terms: Bank wire (T/T), Doc Against Acceptance (D/A), MoneyGram, Credit Card (CC)

Product Showcase
axitinib(CAS ***-85-0)
masitinib(CAS ***-79-5)
tandutinib(***-13-2)
nilotinib(CAS ***-10-0)
caertinib(CAS ***-28-7)
lapatinib
vandetanib( CAS ***-73-3)
Raltegravir(CAS ***-72-1)
moxifloxacin(CAS ***-09-2)
Ezetimibe
axitinib(CAS 319460-85-0)

CL-Link > Health & Medicines in China Health & Medicines in Beijing Medicines in China Medicines in Beijing